Nanobody and Single-Domain Antibody Sequence Listings: Patent Filing Requirements (Deep-Dive Guide)
Prelude Nanobodies and single-domain antibodies (sdAbs) sit at a very interesting intersection of biotechnology and patent law. Scientifically, they are elegant and compact binding domains derived from heavy-chain-only antibodies. Legally, they are among the most sequence-sensitive inventions in the entire life sciences patent landscape. Unlike chemical inventions, where a structure can often be summarized in […]
Bispecific Antibody Sequence Listings: Patent Disclosure Strategies and Requirements
Introduction Bispecific antibodies represent one of the most sophisticated modalities in modern biologics, engineered to bind two distinct antigens or epitopes within a single molecular construct. This dual-targeting capability enables powerful therapeutic mechanisms such as T-cell redirection, tumor microenvironment modulation and multi-pathway inhibition – particularly in oncology and immune-mediated diseases. However, this therapeutic complexity translates […]
Antisense Oligonucleotide Patent Sequence Listings: Regulatory Compliance Essentials
Introduction Antisense oligonucleotides (ASOs) are among the most sequence-dependent inventions in biotechnology, with their identity, function and therapeutic effect directly tied to their nucleotide sequence. As a result, accurate sequence listing preparation is critical for patent protection. The presence of backbone, sugar and base modifications—key to ASO performance—creates additional compliance challenges under WIPO Standard ST.26. […]
Brazil INPI Sequence Listing Requirements for Biotech Patent Applications (ST.26 Standard)
1. Introduction Biotechnology patent filings increasingly depend on precise disclosure of nucleotide and amino acid sequences. In Brazil, the National Institute of Industrial Property (INPI Brazil) has aligned its formal requirements with international standards governed by the World Intellectual Property Organization (WIPO). Since 1 July 2022, Brazil has fully adopted WIPO Standard ST.26, replacing the […]
Indian Patent Office (IPO) Sequence Listing Requirements: A Complete Filing Guide
Linkedin Facebook X-twitter Youtube +1-312-428-5732 info@thesequencelisting.com Home Sequence Listing Service ST.26 Listing Service About Us FAQs Resources Contact Us Hamburger Toggle Menu Articles Indian Patent Office (IPO) Sequence Listing Requirements: A Complete Filing Guide Introduction The rapid growth of biotechnology, genomics, pharmaceuticals, precision medicine, agricultural biotechnology and synthetic biology has transformed the global innovation landscape. […]
IP Australia Sequence Listing Requirements: A Filing Guide for Australian Patents
Prelude Australia is a key jurisdiction for life sciences and biotechnology patents and IP Australia has specific requirements for applications that disclose biological sequences. While these requirements align with WIPO Standard ST.26, they also include Australia-specific procedural and filing rules. Whether you’re filing a direct Australian application, a PCT national phase entry, or a standard […]
WIPO Sequence Software: A Step-by-Step Guide for Patent Preparers
Linkedin Facebook X-twitter Youtube +1-312-428-5732 info@thesequencelisting.com Home Sequence Listing Service ST.26 Listing Service About Us FAQs Resources Contact Us Hamburger Toggle Menu Articles WIPO Sequence Software: A Step-by-Step Guide for Patent Preparers Prelude WIPO Sequence is the free, WIPO-developed software that creates ST.26-compliant XML sequence listings for patent applications. Since January 2022, ST.26 replaced the […]
How Much Does Sequence Listing Preparation Cost? A Practical Pricing Guide
Introduction If your patent application includes nucleotide or amino acid sequences, you will likely need a sequence listing — a standardized, machine-readable document required by patent offices worldwide. Missing or non-compliant listings can delay prosecution, jeopardize filing dates, or create validity risks. Yet many applicants underestimate the cost and complexity involved. Sequence listing preparation can […]
Sequence Listing Essentials for Biotech Startups: A Guide for Early-Stage Companies
Linkedin Facebook X-twitter Youtube +1-312-428-5732 info@thesequencelisting.com Home Sequence Listing Service ST.26 Listing Service About Us FAQs Resources Contact Us Hamburger Toggle Menu Articles Sequence Listing Essentials for Biotech Startups: A Guide for Early-Stage Companies If you are building a biotech company around a novel gene, protein, antibody, or nucleic acid, you will almost certainly encounter […]
CIPO Sequence Listing Requirements: Filing Biotech Patents in Canada
Linkedin Facebook X-twitter Youtube +1-312-428-5732 info@thesequencelisting.com Home Sequence Listing Service ST.26 Listing Service About Us FAQs Resources Contact Us Hamburger Toggle Menu Articles CIPO Sequence Listing Requirements: Filing Biotech Patents in Canada If you are working in the biotech, pharma, or life sciences industry and planning to file a patent in Canada, understanding the CIPO […]